Mobile
  • Search
  • Advanced search
  • Multi-criteria search
  • Who are we ?
  • Log in
  • Sign up
  • Français
  • English

Kusajili – Clinical trials directory

Your research

Clear all filters

Filtres
organs
Specialty
Type
Promoter
  • Trial Manager (1)
  • nct (1)
Country
  • Australia (2)
  • Belgium (2)
  • Denmark (2)
  • France (2)
  • Italy (2)
  • Netherlands (2)
  • Norway (2)
  • Poland (2)
  • Romania (2)
  • Spain (2)
  • Sweden (2)
  • United Kingdom (2)
  • Austria (1)
  • Canada (1)
  • Czech Republic (1)
  • Finland (1)
  • Germany (1)
  • Greece (1)
  • Hungary (1)
  • Israel (1)
  • New Zealand (1)
  • Portugal (1)
  • Russian Federation (1)
  • United States (1)
Source
  • nct (2)
Phase
  • complete (2)

Country: Poland,Romania,Belgium,Australia,Sweden,Netherlands,France,Italy,Denmark
nct Update Il y a 5 ans

FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients The purpose of this study is to provide treatment for patients who have chronic lymphocytic leukemia (CLL), and to compare the use of rituximab added to fludarabine+cyclophosphamide (FC) with FC alone, to determine if rituximab lengthens the time a patient remains free of leukemia symptoms.

  • Country Australia, Belgium, Canada, Denmark, France, Hungary, Italy, Netherlands, New Zealand, Norway, Poland, Romania, Russian Federation, Spain, Sweden, United Kingdom, United States,
  • organs None
  • Specialty None
Closed trial
More information
Trial Manager Update Il y a 5 ans

Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis To compare the therapeutic and radiographic effects and safety between etanercept, methotrexate, and the etanercept/methotrexate combination in patients with rheumatoid arthritis.

  • Country Australia, Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Israel, Italy, Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, United Kingdom,
  • organs None
  • Specialty None
Closed trial
More information

  • 1

Who are we ?

Kusajili was created to respond to a request from physicians to simplify access to patient registries and inclusion. Kusajili is regularly updated according to new French and international trials. [email protected]

Kusajili and MyHomeDoctor

MyHomeDoctor software unique to the world, created with surgeons, for follow-up and analysis of patient follow-up. Kusajili and MyHomeDoctor partners, help clinical research through improved patient follow-up and automatic inclusion.

Sign up

Sign up
Français - English - CGU - Cookies

©2024 Kusajili France - Kusajili International - MedSynApps - MyHomeDoctor.